Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)Tiziano Barbui, Ayalew Tefferi, Guido Finazzi et al.|Blood|2012Cited by 596
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International StudyTiziano Barbui, Ayalew Tefferi, Jüergen Thiele et al.|Journal of Clinical Oncology|2011Cited by 540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patientsAlessandra Carobbio, Tiziano Barbui, Jüergen Thiele et al.|Blood|2011Cited by 448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension studyHeinz Gisslinger, Jiřı́ Schwarz, Christoph Klade et al.|The Lancet Haematology|2020Cited by 351
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaTiziano Barbui, Ayalew Tefferi, Heinz Gisslinger et al.|Blood Cancer Journal|2015Cited by 273